Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Beginning Cash Balance (2016 - 2018)

BioRestorative Therapies (BRTX) has disclosed Beginning Cash Balance for 8 consecutive years, with $6500.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Beginning Cash Balance rose 333.33% year-over-year to $6500.0, compared with a TTM value of $38500.0 through Dec 2018, down 34.2%, and an annual FY2018 reading of $38500.0, down 34.2% over the prior year.
  • Beginning Cash Balance was $6500.0 for Q3 2018 at BioRestorative Therapies, down from $7000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $150030.0 in Q4 2016 and bottomed at $1500.0 in Q3 2017.
  • Average Beginning Cash Balance over 5 years is $50485.5, with a median of $35007.5 recorded in 2017.
  • The sharpest move saw Beginning Cash Balance soared 872.56% in 2015, then crashed 97.2% in 2017.
  • Year by year, Beginning Cash Balance stood at $20524.0 in 2014, then surged by 421.34% to $107000.0 in 2015, then surged by 40.21% to $150030.0 in 2016, then tumbled by 94.67% to $8000.0 in 2017, then decreased by 18.75% to $6500.0 in 2018.
  • Business Quant data shows Beginning Cash Balance for BRTX at $6500.0 in Q3 2018, $7000.0 in Q2 2018, and $25000.0 in Q1 2018.